Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial (Q57956059)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

8 December 2019

main subject

0 references

author

Jørgen Vestbo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

T Sørensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Lange

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Brix

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Torre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K Viskum

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1819-1823

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

9167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Effects of long-term treatment with corticosteroids in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Random-effects models for longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

A survey of models for repeated ordered categorical response data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Update on the "Dutch hypothesis" for chronic respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Longitudinal analyses of airway responsiveness and pulmonary function decline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

Airways responsiveness and development and remission of chronic respiratory symptoms in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910019-3

7 January 2021

10.1016/S0140-6736(98)10019-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359405%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference